Mayo Clinic selected Gianrico Farrugia, MD, to succeed John Noseworthy, MD, as president and CEO of Rochester, Minn.-based Mayo Clinic, the 31-member board of trustees confirmed Aug. 10.
Dr. Noseworthy said in February that he would retire at the end of 2018, following a 28-year career at the health system.
Here are seven things to know about the new hire:
1. Dr. Farrugia has been the vice president of the Mayo system, as well as CEO of Mayo Clinic in Jacksonville, Fla., since 2015.
2. He also has served as director of Mayo Clinic's Center for Individualized Medicine, and he co-founded the Center for Innovation at Mayo Clinic.
3. Dr. Farrugia has spent 30 years as a Mayo physician, jointly appointed in the division of gastroenterology and hepatology, department of internal medicine, and department of physiology and biomedical engineering.
4. In addition, Dr. Farrugia is a member of the Mayo Clinic Board of Trustees and Mayo Clinic Board of Governors.
5. Dr. Farrugia is also a professor of medicine and physiology, and a faculty member in biomedical engineering at Mayo Clinic Graduate School of Biomedical Sciences.
6. He has published more than 250 articles on genomics and the treatment of gastrointestinal motility disorders, and is the co-author of the book, Think Big, Start Small, Move Fast: A Blueprint for Transformation From the Mayo Clinic Center for Innovation.
7. Drs. Noseworthy and Farrugia will work closely together during the transition
"Dr. Farrugia is a visionary and servant leader who brings with him a wealth of experience and knowledge ─ both as an innovator and an executive," Dr. Noseworthy said in a news release. "In partnership with our staff across Mayo Clinic, and with a deep commitment to our values and mission, he will affirm Mayo Clinic's position as the global health care leader for generations to come."